Skip to main content
Clinical Trials/JPRN-UMIN000038709
JPRN-UMIN000038709
Recruiting
未知

A multicenter, prospective feasibility study for definite diagnosis of malignant pleural mesothelioma by pleural effusion cytopathology - Definite Diagnosis of Mesothelioma by Pleural Effusion Cytopathology

Hyogo College of Medicine0 sites100 target enrollmentNovember 28, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Hyogo College of Medicine
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 28, 2019
End Date
March 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)pleural biopsy was already done prior to this study 2\)complicated other malignancies 3\)complicated other intrathoracic disease(empyema, pleuritis)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
CRYOSTAT study: To determine whether early administration of cryoprecipitate in bleeding trauma patients is possible.
ISRCTN55509212HS Blood and Transplant Service (UK)40
Unknown
Not Applicable
Multicenter prospective study of feasibility and safety of radio frequency ablation for malignant biliary stricture under ERCP guidance
JPRN-UMIN000026538Osaka Medical College30
Terminated
Phase 2
Feasibility study of normoxic versus hyperoxic therapy after cardiac arrestCardiovascular - Other cardiovascular diseasesOut-of-hospital cardiac arrest
ACTRN12612001054808Medical Research Institute of New Zealand42
Completed
Phase 1
A multi-centered phase I study of feasibility in endoscopic hand suturing (EHS) of mucosal defects after gastric endoscopic submucosal dissectioearly gastric cancers
JPRN-UMIN000033988ippon Medical School40
Active, not recruiting
Phase 1
Detecting early pre-symptomatic psoriatic arthritis in patients with skin moderate or severe psoriasis - how effective is ustekinumab (Stelara) in limiting joint disease progression and future disability?Psoriatic disease (psoriasis and psoriatic arthritis).MedDRA version: 14.1 Level: LLT Classification code 10066579 Term: Progression of psoriatic arthritis System Organ Class: 100000004859MedDRA version: 14.1 Level: LLT Classification code 10071117 Term: Plaque psoriasis System Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 14.1 Level: LLT Classification code 10037160 Term: Psoriatic arthritis System Organ Class: 100000004859MedDRA version: 14.1 Level: LLT Classification code 10050576 Term: Psoriasis vulgaris System Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 14.1 Level: PT Classification code 10037153 Term: Psoriasis System Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 14.1 Level: LLT Classification code 10037157 Term: Psoriasis of scalp System Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 14.1 Level: LLT Classification code 10063407 Term: Psoriasis genital System Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 14.1 Level: PT Classification code 10028703 Term: Nail psoriasis System Organ Class: 10040785 - Skin and subcutaneous tissue disordersTherapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
EUCTR2012-002640-25-GBniversity of Leeds/Leeds Teaching Hospitals NHS Trust30